Visual function following transpupillary thermotherapy with adjusted laser parameters for the treatment of exudative age-related macular degeneration: A pilot study

Clinical and Experimental Ophthalmology

Volumn 34, Issue 3, 2006, Pages 226-232

  Tranos, Paris ^a   Peter, Neena M ^a,c   Nath, Remin ^a   Singh, Minu V ^a   Wren, Siobhan ^a   Dimitrakos, S ^b   Rassam, Sal ^a   Kon, Chee ^a  

^a WORTHING HOSPITAL   (United Kingdom)

^b AHEPA UNIVERSITY HOSPITAL   (Greece)

^c WESTERN EYE HOSPITAL   (United Kingdom)

Author keywords

Age related macular degeneration; Choroidal neovascularization; Transpupillary thermotherapy

Indexed keywords

FLUORESCEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST SENSITIVITY; DIODE LASER; EYE FUNDUS; FEMALE; FOLLOW UP; HUMAN; MALE; METAMORPHOSIS; PILOT STUDY; POSTOPERATIVE PERIOD; QUESTIONNAIRE; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; TRANSPUPILLARY THERMOTHERAPY; TREATMENT OUTCOME; VISION; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; CHOROIDAL NEOVASCULARIZATION; CONTRAST SENSITIVITY; EXUDATES AND TRANSUDATES; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; LASERS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; PUPIL; QUESTIONNAIRES; VISUAL ACUITY;

EID: 33645735150     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2006.01198.x     Document Type: Article

References (23)

1. Ferris FL III, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol 1984; 102: 1640-2.
2. Oosterhuis JA, Journee-de Korver HG, Kakebeeke-Kemme HM, Bleeker JC. Transpupillary thermotherapy in choroidal melanomas. Arch Ophthalmol 1995; 113: 315-21.
3. Mainster M, Reichel E. Transpupillary thermotherapy for age-related macular degeneration: Long-pulse photocoagulation, apoptosis, and heat shock proteins. Ophthalmic Surg Lasers 2000; 31: 359-73.
4. Newsom R, McAlister JC, Saeed M, McHugh JD. Transpupillary thermotherapy for the treatment of choroidal neovascularisation. Br J Ophthalmol 2001; 85: 173-8.
5. Algvere PV, Libert C, Lindgärde G, Seregard S. Transpupillary thermotherapy of predominantly occult choroidal neovascularisation in age-related macular degeneration with 12 months follow-up. Acta Ophthalmol Scand 2003; 81: 110-17.
6. Klein R, Klein BE, Moss SE. Visual impairment in diabetes. Ophthalmology 1984; 91: 1-9.
7. Mangione CM, Berry S, Spritzer K et al. Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol 1998; 116: 227-33.
8. Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators. Arch Ophthalmol 1998; 116: 1496-504.
9. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 2001; 119: 1050-8.
10. Reichel E, Berrocal AM, Ip M et al. Transpupillary thermotherapy of occult subfoveal choroidal neovascularisation in patients with age-related macular degeneration. Ophthalmology 1999; 106: 1908-14.
11. Ali F. A Comprehensive Overview of Transpupillary Thermotherapy. Japanese Society of Ophthalmic Surgeons Congress, Hiroshima, Japan, 2002.
12. Auer C, Tao Tran V, Herbort CP. Transpupillary thermotherapy for occult subfoveal neovessels in age-related macular degeneration: Importance of patient pigmentation for the determination of laser settings. Klin Monatsbl Augenheilkd 2002; 219: 250-3.
13. Nagpal M, Nagpal K, Sharma S, Puri J, Nagpal PN. Transpupillary thermotherapy for treatment of choroidal neovascularisation secondary to age-related macular degeneration in Indian eyes. Indian J Ophthalmol 2003; 51: 243-50.
14. Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularisation in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularisation - Verteporfin in Photodynamic Therapy Report No. 2. Am J Ophthalmol 2001; 131: 541-60.
15. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin: two year results of two randomized clinical trials - TAP report 2. Arch Ophthalmol 2001; 119: 198-207.
16. Stevens TS, Bressler NM, Maguire MG et al. Occult choroidal neovascularisation in age-related macular degeneration: A natural history study. Arch Ophthalmol 1997; 115: 345-350.
17. Leat SJ, Woodhouse JM. Reading performance with low vision aids: relationship with contrast sensitivity. Ophthalmic Physiol Opt 1993; 13: 9-16.
18. McClure ME, Hart PM, Jackson AJ, Stevenson MR, Chakravarthy U. Macular degeneration: Do conventional measurements of impaired visual function equate with visual disability? Br J Ophthalmol 2000; 84: 244-50.
19. Rubin GS. Prevalence of vision disabilities and their relationship to visual impairment. In: Massof R, Lidoff L, eds. Low Vision Rehabilitation: Policy, Service Delivery, Policy and Funding. New York: AFB Press, 2001; 27-38.
20. Lennerstrand G, Ahlstrom CO. Contrast sensitivity in macular degeneration and the relationship to subjective visual impairment. Acta Ophthalmol (Copenh) 1989; 67: 225-33.
21. Rubin GS, Bandeen-Roche K, Huang GH et al. The association of multiple visual impairments with self reported visual disability: SEE project. Invest Ophthalmol Vis Sci 2001; 42: 64-72.
22. Ellis JD, Mallik TY, Taubert MA, Barr A, Baines PS. Surgery for full thickness macular holes with short-duration prone posturing: Results of a pilot study. Eye 2000; 14: 307-12.
23. Miskala PH, Hawkins BS, Mangione CM et al. Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: Findings in patients with subfoveal choroidal neovascularisation - SST Report No. 1. Arch Ophthalmol 2003; 121: 531-539.